文献速递甲状腺疾病

分化型甲状腺癌全切及碘131消融后基础甲状腺球蛋白低或检测不到者无需颈部超声

Low or Undetectable Basal Thyroglobulin Levels Obviate the Need for Neck Ultrasound in Differentiated Thyroid Cancer Patients After Total Thyroidectomy and 131I Ablation.
PubMed 文献 · Thyroid · 2018-05-14

该回顾性数据库研究分析了1996年6月15日至2012年7月1日期间773例分化型甲状腺癌患者的3176次颈部超声检查,评估超声在随访中的临床价值。结果显示,颈部超声总体灵敏度75.8%、特异度76.1%、阳性预测值23.8%、阴性预测值97.0%、准确率76.0%;低危与高危患者间无显著差异。自2007年1月起,甲状腺球蛋白<1 μg/L的患者中未再观察到真阳性或假阴性颈部超声。结论认为全甲状腺切除及碘131消融后,颈部超声应仅用于抗甲状腺球蛋白抗体阴性且甲状腺球蛋白≥1 μg/L的患者。

要点

  • 颈部超声总体阳性预测值仅23.8%,假阳性率高。
  • 甲状腺球蛋白<1 μg/L者阴性预测值高,2007年后无真阳性或假阴性超声。
  • 全切及碘131消融后,颈部超声应仅用于抗Tg抗体阴性且Tg≥1 μg/L者。

核心结论

  • 全甲状腺切除及碘131消融后,颈部超声应仅用于抗甲状腺球蛋白抗体阴性且甲状腺球蛋白≥1 μg/L的患者。

研究设计与样本

  • 回顾性数据库研究,纳入773例分化型甲状腺癌患者,共分析1996年6月15日至2012年7月1日期间的3176次颈部超声检查,以超声后6个月内进一步诊断或治疗结果评估超声准确性。

主要发现

  • 3176次颈部超声中,真阴性2199次、真阳性216次、假阳性692次(涉及339例患者,占43.9%,其中低危170例)、假阴性69次。
  • 低危与高危患者之间无显著差异。
  • 甲状腺球蛋白检测不到与低可检测(<1 μg/L)两组之间无显著差异。
  • 上述两组阳性预测值均显著低于甲状腺球蛋白≥1 μg/L组,阴性预测值均显著高于甲状腺球蛋白≥1 μg/L组。

临床怎么用

  • 作者结论认为,全甲状腺切除及碘131消融后,颈部超声应仅用于抗甲状腺球蛋白抗体阴性且甲状腺球蛋白≥1 μg/L的患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neck ultrasound (NUS) is currently seen as a main component of follow-up of differentiated thyroid cancer (DTC) and is usually performed regardless of non-stimulated thyroglobulin (Tg) levels. The aim of this study was to determine whether there is a clinical benefit from such a routine NUS in DTC patients. METHODS: A retrospective database study was conducted of 3176 cervical ultrasound exams performed in 773 patients between June 15, 1996, and July 1, 2012. The accuracy of ultrasound results was assessed based on the results of further diagnostic and/or therapeutic procedures within six months of a particular ultrasound. RESULTS: A total of 2199 NUS exams were classified as true negative, 216 as true positive, 692 as false positive in 339 (43.9%) individual patients, 170 of whom were low risk, and 69 as false negative. Thus, overall sensitivity, specificity, positive predictive value, negative predictive value, and accuracy [confidence interval] were 75.8% [70.1-81.5%], 76.1% [74.3-77.8%], 23.8% [18.1-29.5%], 97.0 [96.2-97.7%], and 76.0% [74.3-77.7%], respectively. No significant differences were found between low- and high-risk patients. There were no significant differences between patients with an undetectable and a low detectable (<1 μg/L) Tg level. However, these two groups both showed significantly lower positive predictive value and higher negative predictive value than patients with a Tg ≥1 μg/L. From January 2007 onwards, true-positive and false-negative neck ultrasounds were no longer observed in patients with Tg <1 μg/L. CONCLUSION: After total thyroidectomy and 131I ablation, neck ultrasound should be reserved only for anti-Tg antibody negative patients with a Tg level of ≥1 μg/L.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Verburg FA, Mäder U, Giovanella L, et al. Low or Undetectable Basal Thyroglobulin Levels Obviate the Need for Neck Ultrasound in Differentiated Thyroid Cancer Patients After Total Thyroidectomy and 131I Ablation. Thyroid. 2018. PMID: 29665748. doi:10.1089/thy.2017.0352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。